What is Ivermectin 12 mg?
Ivermectin 12 mg is a higher-dose formulation of the antiparasitic medication commonly used to treat various parasitic infections in humans. It is particularly effective against infections caused by specific types of parasites, including certain worms, lice, and mites.
Clinical Uses of Ivermectin 12 mg
Ivermectin 12 mg is primarily prescribed for the treatment of:
- Onchocerciasis (River Blindness): A parasitic disease caused by Onchocerca volvulus.
- Strongyloidiasis: An intestinal infection caused by the roundworm Strongyloides stercoralis.
- Scabies: A skin infestation caused by mites.
- Pediculosis (Lice Infestations): Effective in treating infestations of head lice and pubic lice.
Mechanism of Action
Ivermectin works by binding to specific proteins in the parasite’s nerve and muscle cells, leading to an increase in cell membrane permeability to chloride ions. This results in paralysis and death of the parasite, aiding in the elimination of the infection from the host.
Dosage and Administration
The standard dosage for Ivermectin 12 mg is typically a single dose taken orally with water on an empty stomach. Depending on the severity of the infection, additional doses may be required, as advised by a healthcare provider.
Precautions and Side Effects
Before starting treatment with Ivermectin 12 mg, it is important to inform your healthcare provider about any other medications you are taking and any pre-existing health conditions. Common side effects include dizziness, nausea, and diarrhea, while more serious side effects, such as neurological symptoms, should be reported to a healthcare provider immediately.
Use in COVID-19
During the COVID-19 pandemic, Ivermectin 12 mg gained attention as a potential treatment for COVID-19. However, major health organizations, including the FDA and WHO, have not approved its use for this purpose due to insufficient evidence supporting its efficacy and safety in treating COVID-19.
Conclusion
Ivermectin 12 mg remains a valuable medication for the treatment of specific parasitic infections. Its use in the context of COVID-19 is not supported by current scientific evidence, and it should be used under medical supervision for approved indications only.